Free Trial

This company has been marked as potentially delisted and may not be actively trading.

NASDAQ:BABY

Natus Medical (BABY) Stock Price, News & Analysis

Natus Medical logo

About Natus Medical Stock (NASDAQ:BABY)

Advanced Chart

Key Stats

Today's Range
N/A
50-Day Range
$26.75
$31.92
52-Week Range
N/A
Volume
22 shs
Average Volume
165,325 shs
Market Capitalization
$1.12 billion
P/E Ratio
23.21
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

Natus Medical Incorporated provides neurology, newborn care, and hearing and balance assessment healthcare products and services worldwide. It offers products and services used for the screening, diagnosis, detection, treatment, monitoring, and tracking of common medical ailments in newborn care, hearing impairment, neurological dysfunction and neurosurgical treatments, epilepsy, sleep disorders, neuromuscular diseases, and balance and mobility disorders. The company also provides computerized neurodiagnostic systems for audiology, neurology, polysomnography, and neonatology; and software systems for managing and tracking disorders and diseases for public health laboratories. In addition, it offers electroencephalography, long term monitoring, intensive care unit monitoring, electromyography, sleep analysis or polysomnography, and intra-operative monitoring solutions. Further, the company provides hearing screening products; diagnostic hearing assessment products to screen for/or diagnose hearing loss, or to identify abnormalities affecting the peripheral and central auditory nervous systems; balance and mobility systems to diagnose and assist in treating balance disorders; and thermoregulation products to control the incubators and warmers. Additionally, it offers jaundice management products; brain injury products; NICVIEW, a live streaming video for families with babies in the neonatal intensive care unit (NICU); essential products used in the everyday operation of NICU; and eye imaging systems and products used in the advanced science and practice of neonatal and pediatric retinal imaging. The company also provides computer-based audiological, otoneurologic, and vestibular instrumentation and sound rooms to hearing and balance care professionals. It serves hospitals, clinics, laboratories, physicians, nurses, audiologists, and governmental agencies. Natus Medical Incorporated was incorporated in 1987 and is headquartered in Pleasanton, California.

Natus Medical Stock Analysis - MarketRank™

See Top-Rated MarketRank™ Stocks
46th Percentile Overall Score

BABY MarketRank™: 

Natus Medical scored higher than 46% of companies evaluated by MarketBeat, and ranked 633rd out of 942 stocks in the medical sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

  • Consensus Rating

    There is not enough analysis data for Natus Medical.

  • Earnings Growth

    Earnings for Natus Medical are expected to grow by 24.41% in the coming year, from $1.27 to $1.58 per share.

  • Price to Earnings Ratio vs. the Market

    The P/E ratio of Natus Medical is 23.21, which means that it is trading at a less expensive P/E ratio than the market average P/E ratio of about 24.29.

  • Price to Earnings Ratio vs. Sector

    The P/E ratio of Natus Medical is 23.21, which means that it is trading at a less expensive P/E ratio than the Medical sector average P/E ratio of about 26.75.

  • Short Interest

    There is no current short interest data available for BABY.
  • Dividend Yield

    Natus Medical does not currently pay a dividend.

  • Dividend Growth

    Natus Medical does not have a long track record of dividend growth.

  • Short Interest

    There is no current short interest data available for BABY.
  • Search Interest

    1 people have searched for BABY on MarketBeat in the last 30 days.
  • Insider Buying vs. Insider Selling

    In the past three months, Natus Medical insiders have not sold or bought any company stock.

  • Percentage Held by Insiders

    Only 1.65% of the stock of Natus Medical is held by insiders.

  • Percentage Held by Institutions

    91.56% of the stock of Natus Medical is held by institutions. High institutional ownership can be a signal of strong market trust in this company.

  • Read more about Natus Medical's insider trading history.
Receive BABY Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Natus Medical and its competitors with MarketBeat's FREE daily newsletter.

BABY Stock News Headlines

The End of Elon Musk…?
The End of Elon Musk? Don't make him laugh. Jeff Brown has been hearing this same tired story for years, and he's been proven right time and time again. And now, while the media focuses on Tesla's "demise," he's uncovered an AI breakthrough that's about to make Elon's doubters eat their words yet again. According to his research, if you listen to the media and miss out on Elon's newest breakthrough, it's going to cost you the fortune of a lifetime.
See More Headlines

BABY Stock Analysis - Frequently Asked Questions

Natus Medical Inc (NASDAQ:BABY) released its quarterly earnings data on Wednesday, October, 24th. The medical equipment provider reported $0.40 earnings per share for the quarter, missing the consensus estimate of $0.42 by $0.02. The firm's revenue for the quarter was up 6.5% on a year-over-year basis.

Natus Medical (BABY) raised $9 million in an IPO on Wednesday, March 8th 2023. The company issued 1,766,618 shares at a price of $5.00 per share.

Based on aggregate information from My MarketBeat watchlists, some other companies that Natus Medical investors own include Bristol-Myers Squibb (BMY), Meta Platforms (META), Starbucks (SBUX), Intel (INTC), Walt Disney (DIS), Gilead Sciences (GILD) and Activision Blizzard (ATVI).

Company Calendar

Last Earnings
10/24/2018
Today
6/15/2025

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Sector
Medical
Industry
Electromedical Equipment
Sub-Industry
Health Care Equipment
Current Symbol
NASDAQ:BABY
Fax
N/A
Employees
1,729
Year Founded
N/A

Profitability

Trailing P/E Ratio
23.21
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
-$22.93 million
Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
$530.89 million
Price / Cash Flow
9.39
Book Value
$11.80 per share
Price / Book
N/A

Miscellaneous

Free Float
N/A
Market Cap
$1.12 billion
Optionable
Optionable
Beta
0.57
10 Best Cheap Stocks to Buy Now Cover

MarketBeat just released its list of 10 cheap stocks that have been overlooked by the market and may be seriously undervalued. Enter your email address and below to see which companies made the list.

Get This Free Report

This page (NASDAQ:BABY) was last updated on 6/15/2025 by MarketBeat.com Staff
From Our Partners